Jump Financial’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Sell
40,500
-50,375
-55% -$581K ﹤0.01% 1518
2026
Q1
$926K Buy
+90,875
New +$980K 0.01% 960
2023
Q3
Sell
-22,830
Closed -$2.1M 2098
2023
Q2
$2.1M Buy
22,830
+2,830
+14% +$252K 0.08% 368
2023
Q1
$2.07M Buy
+20,000
New +$2.22M 0.08% 354
2022
Q4
Sell
-3,483
Closed -$377K 1854
2022
Q3
$377K Buy
+3,483
New +$499K 0.01% 1025
2021
Q4
Sell
-5,295
Closed -$1.02M 1586
2021
Q3
$1.02M Buy
+5,295
New +$1.3M 0.07% 288
2021
Q2
Sell
-1,500
Closed -$318K 1281
2021
Q1
$318K Buy
+1,500
New +$359K 0.03% 585

Other funds holding MED

Jump Financial's MED Position: Q2 2026 in Review

Jump Financial reduced its Medifast (MED) stake by 55% in Q2 2026, selling an estimated $581K and leaving 40,500 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #1518.

Jump Financial first reported a position in MED in Q1 2021 and has held it in 7 quarters since. The position peaked at $2.1M in Q2 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Jump Financial held 40,500 shares of Medifast worth $430K as of Q2 2026.
  • Jump Financial sold 50,375 Medifast shares in Q2 2026, an estimated $581K.
  • Medifast made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1518 holding.
  • Jump Financial first reported a position in Medifast in Q1 2021 and has held it in 7 quarters since.
  • Jump Financial's Medifast position peaked at $2.1M in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.